162 related articles for article (PubMed ID: 23110810)
1. A population-based cohort study in Taiwan--use of insulin sensitizers can decrease cancer risk in diabetic patients?
Kao CH; Sun LM; Chen PC; Lin MC; Liang JA; Muo CH; Chang SN; Sung FC
Ann Oncol; 2013 Feb; 24(2):523-530. PubMed ID: 23110810
[TBL] [Abstract][Full Text] [Related]
2. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
4. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.
Koro C; Barrett S; Qizilbash N
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841
[TBL] [Abstract][Full Text] [Related]
5. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
[TBL] [Abstract][Full Text] [Related]
6. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.
Aguilar D; Bozkurt B; Pritchett A; Petersen NJ; Deswal A
J Am Coll Cardiol; 2007 Jul; 50(1):32-6. PubMed ID: 17601542
[TBL] [Abstract][Full Text] [Related]
7. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
[TBL] [Abstract][Full Text] [Related]
8. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
9. Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study.
Chen SW; Tsan YT; Chen JD; Hsieh HI; Lee CH; Lin HH; Wang JD; Chen PC;
Diabetes Care; 2013 Feb; 36(2):369-75. PubMed ID: 23043163
[TBL] [Abstract][Full Text] [Related]
10. Diffusion patterns of new anti-diabetic drugs into hospitals in Taiwan: the case of thiazolidinediones for diabetes.
Wen YW; Huang WF; Lee YC; Kuo KN; Tsai CR; Tsai YW
BMC Health Serv Res; 2011 Jan; 11():21. PubMed ID: 21281475
[TBL] [Abstract][Full Text] [Related]
11. Effects of thiazolidinediones on cardiovascular events in patients with type 2 diabetes mellitus after drug-eluting stent implantation: a retrospective cohort study using the national health insurance database in Taiwan.
Yeh HT; Hsieh CF; Tsai YW; Huang WF
Clin Ther; 2012 Apr; 34(4):885-93. PubMed ID: 22440193
[TBL] [Abstract][Full Text] [Related]
12. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes.
Chao TF; Leu HB; Huang CC; Chen JW; Chan WL; Lin SJ; Chen SA
Int J Cardiol; 2012 Apr; 156(2):199-202. PubMed ID: 21930315
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure.
Granberry MC; Hawkins JB; Franks AM
Am J Health Syst Pharm; 2007 May; 64(9):931-6. PubMed ID: 17468147
[TBL] [Abstract][Full Text] [Related]
15. Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study.
Gower EW; Lovato JF; Ambrosius WT; Chew EY; Danis RP; Davis MD; Goff DC; Greven CM;
Am J Ophthalmol; 2018 Mar; 187():138-147. PubMed ID: 29275147
[TBL] [Abstract][Full Text] [Related]
16. Use of thiazolidinediones and risk of bladder cancer: disease or drugs?
Bazelier MT; de Vries F; Vestergaard P; Leufkens HG; De Bruin ML
Curr Drug Saf; 2013 Nov; 8(5):364-70. PubMed ID: 24215315
[TBL] [Abstract][Full Text] [Related]
17. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
Bazelier MT; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; Vestergaard P; de Vries F
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):507-14. PubMed ID: 22392882
[TBL] [Abstract][Full Text] [Related]
18. The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan.
Huang MY; Chung CH; Chang WK; Lin CS; Chen KW; Hsieh TY; Chien WC; Lin HH
Am J Cancer Res; 2017; 7(7):1606-1616. PubMed ID: 28744408
[TBL] [Abstract][Full Text] [Related]
19. Relationship between cumulative dose of thiazolidinediones and clinical outcomes in type 2 diabetic patients with history of heart failure: a population-based cohort study in Taiwan.
Hsiao FY; Tsai YW; Wen YW; Chen PF; Chou HY; Chen CH; Kuo KN; Huang WF
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):786-91. PubMed ID: 20607752
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.
Liao KF; Lai SW; Li CI; Chen WC
J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
